about
Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters.Contamination with E1A-positive wild-type adenovirus accounts for species-specific stimulation of islet cell proliferation by CCK: a cautionary note.Cholecystokinin is up-regulated in obese mouse islets and expands beta-cell mass by increasing beta-cell survivalα-Hemoglobin-stabilizing protein is a sensitive and specific marker of erythroid precursors.Vertical sleeve gastrectomy specimens have a high prevalence of unexpected histopathologic findings requiring additional clinical management.Overlapping Morphologic and Immunohistochemical Features of Hashimoto Thyroiditis and IgG4-Related Thyroid Disease.Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agentThe role of molecular pathology in the diagnosis of cutaneous lymphomasOutcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma.MYC immunohistochemical and cytogenetic analysis are required for identification of clinically relevant aggressive B cell lymphoma subtypes.Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus.Concurrent STAT3, DNMT3A, and TET2 mutations in T-LGL leukemia with molecularly distinct clonal hematopoiesis of indeterminate potential.Ibrutinib is an effective treatment for B-cell prolymphocytic leukaemia.Tracheobronchopathia osteochondroplastica presenting as a single dominant tracheal massCholine Transporter Immunohistochemistry: An Effective Substitute for Acetylcholinesterase Histochemistry to Diagnose Hirschsprung Disease With Formalin-fixed Paraffin-embedded Rectal BiopsiesA Missing Link: Sarcoid-Lymphoma SyndromeNipple leiomyoma: A rare neoplasm with a broad spectrum of histologic appearancesMast cell sarcoma with concurrent mast cell leukaemiaPrimary Extranodal Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the ThyroidCD30+ large B cell lymphoma with anaplastic features and complete loss of B cell marker expression arising from follicular lymphomaThe combination of NPM1, DNMT3A, and IDH1/2 mutations leads to inferior overall survival in AMLErythroblastic sarcoma with rare PDGFRA rearrangement responding to tyrosine kinase inhibitor therapy
P50
Q30701433-81B10443-29D8-4895-BB3E-06352AF4E4C6Q33634233-FCF9AD0B-6ED7-45E1-BBFF-563B81FC0595Q34132510-06B7FD3C-FE1A-4E80-95FD-85BE8B1B669AQ36242687-5A7100FE-216C-4D71-A2AD-45C7C6890820Q38418864-640F51DC-FA7E-47F2-8C2A-30E254FAABE9Q38433274-CF48865F-F55A-4535-B989-8387376BC9E2Q39717448-054A4326-E984-4C63-A973-56419C0FF89DQ42355552-BEE6C0E3-DDBF-4F64-A8BE-1254C71BE7D8Q47589672-9F76660B-FC21-415F-B5C3-FD2D290A6568Q47861237-9F2473DB-B045-4224-A878-43F613FFC050Q48088931-C97085CE-8117-444F-81FF-94EE57F61C16Q51373787-84C61C81-4A28-4071-97FB-19A866AB768CQ54185867-66C7BB61-96B4-446B-84D2-C5032717AC18Q84582502-8714A656-052B-441E-920B-87FE8D989D68Q88389895-2C1C448E-1A47-4F6A-984C-0893AF748038Q90918500-F2B86467-E029-4119-A4CA-C3BA6A6DBF7EQ91134685-CE25FBD6-6B40-4F05-8103-4DF995F8B5FCQ91528862-D7F48C93-03BE-42E4-94BD-FD8B2DCE5BB8Q91778160-6399BD77-141C-4804-92A1-1ADBC46364F2Q92157704-95A8B984-8C54-4DBF-A9E3-79C44E79D68FQ92402377-952D996C-C098-4BAA-8807-2ED670D95FA6Q92730269-426BDC3C-60DA-495F-8B07-3127CF0A6D8F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Philipp W Raess
@ast
Philipp W Raess
@en
Philipp W Raess
@es
Philipp W Raess
@nl
Philipp W Raess
@sl
type
label
Philipp W Raess
@ast
Philipp W Raess
@en
Philipp W Raess
@es
Philipp W Raess
@nl
Philipp W Raess
@sl
prefLabel
Philipp W Raess
@ast
Philipp W Raess
@en
Philipp W Raess
@es
Philipp W Raess
@nl
Philipp W Raess
@sl
P106
P21
P31
P496
0000-0002-6841-4993